Therefore, although myeloid leukemias are heterogeneous in terms of phenotype, disease progression, prognosis, and response to therapy, TWIST-1 appears to be a common pathogenic factor for both AML and CML, suggesting its importance in the development of myeloid leukemias. The gene discussed is TWIST1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.